Selegiline hydrochlorideProduct ingredient for Selegiline
- Name
- Selegiline hydrochloride
- Drug Entry
- Selegiline
A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.
- Accession Number
- DBSALT000260
- Structure
Structure for Selegiline hydrochloride (DBSALT000260)
- Synonyms
- Selegiline HCl